Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Carcinoma × Radioimmunotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1

Interventions

Etoposide 68 Carboplatin 57 Cisplatin 52 durvalumab 28 Irinotecan 28 Radiotherapy 26 Topotecan 20 atezolizumab 17 anlotinib 15 Drug Therapy 14 Nivolumab 13 Radiosurgery 12 apatinib 11 Gemcitabine 11 toripalimab 10 Platinum 10 Paclitaxel 10 Docetaxel 9 olaparib 7 PM 01183 7 Ipilimumab 7 Bevacizumab 7 tislelizumab 6 pembrolizumab 6 irinotecan sucrosofate 6 Temozolomide 6 Counseling 6 Albumin-Bound Paclitaxel 6 Vinorelbine 5 Magnetic Resonance Spectroscopy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03467360 2026-01-20

ICAR

Centre Antoine Lacassagne

Phase 1 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡